1621175-65-2
1621175-65-2 結(jié)構(gòu)式
基本信息
16211175-65-2
GPR39-C3
TC-G-1008
GPR39C3
GPR39 C3
TC-G-1008 (GPR39-C3)
N-[3-Chloro-4-[[[2-(methylamino)-6-(2-pyridinyl)-4-pyrimidinyl]amino]methyl]phenyl]methanesulfonamide
N-(3-Chloro-4-(((2-(methylamino)-6-(pyridin-2-yl)pyrimidin-4-yl)amino)methyl)phenyl)methanesulfonamide
Methanesulfonamide, N-[3-chloro-4-[[[2-(methylamino)-6-(2-pyridinyl)-4-pyrimidinyl]amino]methyl]phenyl]-
物理化學(xué)性質(zhì)
DMSO:PBS (pH 7.2) (1:5):0.16(Max Conc. mg/mL);0.38(Max Conc. mM)
Ethanol:2.0(Max Conc. mg/mL);4.77(Max Conc. mM)
| 報價日期 | 產(chǎn)品編號 | 產(chǎn)品名稱 | CAS號 | 包裝 | 價格 |
| 2025/02/05 | HY-103007 | TC-G-1008 | 1621175-65-2 | 1 mg | 500元 |
| 2025/02/05 | HY-103007 | CS-2374 TC-G-1008 | 1621175-65-2 | 5mg | 1100元 |
| 2025/02/05 | HY-103007 | CS-2374 TC-G-1008 | 1621175-65-2 | 10mM * 1mLin DMSO | 1210元 |
常見問題列表
| Target | Value |
|
rGPR39
(Cell-free assay) | 0.4 nM(EC50) |
|
hGPR39
(Cell-free assay) | 0.8 nM(EC50) |
TC-G-1008 shows selectivity over a panel of kinases (IC 50 s>10 μM) and does not exhibit relevant binding affinity for the related ghrelin and neurotensin-1 receptors (IC 50 s>30 μM). In HEK293-GPR39 cells, GPR39-C3, which is a positive allosteric modulator, activates cAMP production (downstream of Gs), IP1 accumulation (downstream of Gq), SRF-RE-dependent transcription (downstream of G12/13), and β-arrestin recruitment. GPR39-C3 induces dose- and time-dependent loss of response in cAMP production by second challenge of the compound.
Rat and mouse plasma protein binding for TC-G-1008 is measured as 99.3% and 99.1%, respectively. TC-G-1008 is orally bioavailable in mice and robustly induces acute GLP-1 levels. Upon single oral doses of 10, 30, and 100 mg/kg of aqueous suspensions in 0.5% methylcellulose/0.1% Tween 80, TC-G-1008 achieves, between 1 and 1.5 h, maximal exposures of 1.4, 6.1, and 25.3 μM, respectively.